You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Chemistry
Large Scale Synthesis
Compound scale-up is a crucial driver to advance your drug discovery project forward. Scaling drug candidates from milligram to kilogram can be challenging and requires specialist knowledge. It is an important part of IND declaration data.
Services include:
- Preparation of non-GMP API to support pre-IND studies
- Preparation of Kg scale advanced intermediate to initiate GMP API manufacture
- Support for medicinal chemistry programs (key intermediates)
Learn more about